FIELD: biotechnology.
SUBSTANCE: proposed is a polypeptide complex exhibiting cell-mediated cytotoxicity, as well as a corresponding vector, cell, method, pharmaceutical composition.
EFFECT: method expands the range of means of treating various types of cancerous tumours.
38 cl, 26 dwg, 3 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
CYTOTOXICITY-INDUCING THERAPEUTIC AGENT | 2011 |
|
RU2663123C2 |
CYTOTOXICITY-INDUCING THERAPEUTIC AGENT | 2022 |
|
RU2824285C2 |
CYTOTOXICITY-INDUCING THERAPEUTIC AGENT | 2015 |
|
RU2812875C1 |
METHOD OF MODIFICATION OF POLYPEPTIDE FOR PURIFICATION OF POLYPEPTIDE MULTIMERS | 2010 |
|
RU2606264C2 |
CELL DAMAGE INDUCING THERAPEUTIC MEDICINAL PRODUCT FOR ANTICANCER THERAPY | 2017 |
|
RU2746754C2 |
ANTIBODIES BINDING TO HLA-A2/WT1 | 2018 |
|
RU2815176C2 |
ANTIBODIES BINDING TO CD3 | 2019 |
|
RU2810924C2 |
ANTIBODIES BINDING TO GPRC5D | 2019 |
|
RU2797268C2 |
METHOD FOR SELECTION AND OBTAINING OF HIGHLY SELECTIVE AND MULTISPECIFIC TARGETING GROUPS WITH SPECIFIED PROPERTIES, INCLUDING AT LEAST TWO DIFFERENT BINDING GROUPS, AND THEIR APPLICATIONS | 2013 |
|
RU2639287C2 |
ANTIBODIES TO CD38 AND COMBINATIONS WITH ANTIBODIES TO CD3 AND CD28 | 2018 |
|
RU2812910C2 |
Authors
Dates
2022-06-21—Published
2011-11-30—Filed